Why the study?
The impact of chronic kidney disease on long-term outcomes after AMI in the era of modern primary PCI and optimal medical therapy remains debated.
Does the presence of chronic kidney disease increase in-hospital and 3-year mortality and MACE in patients with acute myocardial infarction treated by contemporary PCI and optimal medical therapy?
Does the presence of chronic kidney disease increase in-hospital and 3-year mortality and MACE in patients with acute myocardial infarction treated by contemporary PCI and optimal medical therapy?
Answers are grounded in this paper and cite their sources.
In the contemporary era of primary PCI and optimal medical therapy, chronic kidney disease remains a strong, independent predictor of in-hospital and 3-year mortality and MACE following acute myocardial infarction.
BACKGROUND: The impact of chronic kidney disease (CKD) on long-term outcomes following acute myocardial infarction (AMI) in the era of modern primary PCI with optimal medical therapy is still in debate. METHODS AND While the primary endpoint was all-cause mortality, the secondary endpoint was major adverse cardiac events (MACE), defined as a composite of all-cause death, cardiac failure, myocardial infarction (MI) and stroke. Of the 3,281 patients, 1,878 had no CKD, 1,073 had moderate CKD and 330 had severe CKD. Pre-person-days age- and sex-adjusted in-hospital mortality significantly increased from 0.014% in no CKD through 0.042% in moderate CKD to 0.084% in severe CKD (P<0.0001). Three-year mortality and MACE significantly deteriorated from 5.09% and 15.8% in no CKD through 16.3% and 38.2% in moderate CKD to 36.7% and 57.9% in severe CKD, respectively (P<0.0001). C-index significantly increased from the basic model of 0.815 (0.788-0.841) to 0.831 (0.806-0.857), as well as 0.731 (0.708-0.755) to 0.740 (0.717-0.764) when adding CKD stage to the basic model in predicting 3-year mortality (P=0.013; net reclassification improvement [NRI] 0.486, P<0.0001) and MACE (P=0.046; NRI 0.331, P<0.0001) respectively. CONCLUSIONS: CKD remains a useful predictor of in-hospital and 3-year mortality as well as MACE after AMI in the modern PCI and optimal medical therapy era.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: